CAR T-Cell Therapy

As a certified treatment center, the WVU Cancer Institute is able to offer this treatment to patients up to 25 years old who have acute lymphoblastic leukemia that has either relapsed or is refractory, meaning the disease is resistant to treatment. It is also used in patients with non-Hodgkin lymphoma who have relapsed or are refractory after having at least two other types of treatment, chemotherapy, and/or allogeneic stem cell transplant. Learn more about this groundbreaking therapy here.

About the Presenter

Abraham Kanate, MD
Assistant Professor

Sign up for Clinical Advances e-news

and get regular updates emailed directly to your inbox such as:

    Latest procedures and services | New physicians and clinics | Clinical trials and innovations